Ali Esparham

29 papers receiving 313 citations

Ali Esparham's Hit Papers

RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin–RGD interactions 2024 · 145 citations
1450+1Years since publication4080120

Peers

Ali Esparham
Comparison fields: 5 of 74
  • Biomaterials 49
  • Surgery 72
  • Molecular Medicine 8
  • Immunology and Allergy 7
  • Toxicology 4
Replace Kazuyuki Hayashida with:
Kazuyuki Hayashida Japan
Zhongni Liu China
Riina Harjumäki Finland
Kun-Zhe Wu China
Jingyi Lu China
Hu Tian China
Darryl T. Martin United States
Helena Senta Canada
Shi‐xin Du China
Ali Esparham relative to Kazuyuki Hayashida Japan Kazuyuki Hayashida's profile →
Citations per field
00.5×10×14.8×
Kazuyuki Hayashida · 1×
Citations per year

Countries citing papers authored by Ali Esparham

Since Specialization
Citations

This map shows the geographic impact of Ali Esparham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Esparham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Esparham more than expected).

Fields of papers citing papers by Ali Esparham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Esparham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Esparham. The network helps show where Ali Esparham may publish in the future.

Co-authors

The 25 scholars most cited alongside Ali Esparham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ali Esparham Line = papers co-authored together Ali Esparham links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.

#Work
1
RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin–RGD interactions
Hit paper breakdown →
2024145
2 202327
3 202219
4 202216
5 202313
6 202211
7 202311
8 202411
9 20239
10 20239
11 20237
12 20224
13 20234
14 20233
15 20243
16 20223
17 20233
18 20233
19 20253
20 20252

About Ali Esparham

Ali Esparham is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Molecular Biology and Pathology and Forensic Medicine, having authored 34 papers that have together received 316 indexed citations. Recurring topics across this work include Bariatric Surgery and Outcomes (13 papers), Esophageal and GI Pathology (3 papers), Gastric Cancer Management and Outcomes (3 papers), Diabetes Treatment and Management (2 papers), Cardiovascular Disease and Adiposity (2 papers), Advanced Nanomaterials in Catalysis (2 papers), Gallbladder and Bile Duct Disorders (2 papers) and Cardiovascular Function and Risk Factors (2 papers). The work is most often cited by research in Biomaterials (49 citations), Surgery (72 citations), Molecular Medicine (8 citations), Immunology and Allergy (7 citations) and Toxicology (4 citations). Ali Esparham has collaborated with scholars based in Iran, United States and Australia. Frequent co-authors include Hossein Javid, Mahsa Akbari Oryani, Mehdi Karimi‐Shahri, Mahboubeh Tajaldini, Seyed Isaac Hashemy, Zhamak Khorgami, Reza Assaran Darban, Sattar Gorgani‐Firuzjaee, Saeed Shoar and Mohammad Hossein Boskabady. Their work appears in journals such as Obesity Surgery, Surgery for Obesity and Related Diseases, Naunyn-Schmiedeberg s Archives of Pharmacology, Annals of Surgical Oncology and Surgical Endoscopy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact